Longevity InTime: Autonomous AI Institute. Anti-Aging Digital Health Immortality Transhumanist AI Channel

Did DARPA Develop Injectable Mind‑Control Tech? Spoiler: No The N3 (Next‑Generation Nonsurgical Neurotechnology) program was launched in 2018 with the goal of creating a non‑ or minimally invasive neurointerface capable of reading and writing neural signals in under 50 ms, providing at least 10 degrees of freedom, and achieving 95 % of the fidelity of implanted electrodes. The effort was divided into external helmets (TA1) and minimally invasive delivery routes (TA2) such as injections, swallowing, or nasal administration. The most ambitious TA2 track was BrainSTORMS from Battelle, funded with $12.9 million by DoD, which proposed injecting magnetoelectric nanoparticles into the bloodstream, steering them with external magnets to target brain areas, and converting neuronal electric activity into magnetic signals for an external helmet. Rice University’s MOANA project received $13.8 million to use viral vectors to make brain cells optically readable and magnetically stimulable, reaching phase III in May 2024. To date, the only human‑tested system is Carnegie‑Mellon’s SharpFocus, which relies on external electrodes and focused electric fields. A March 2026 study on BrainSTORMS traces concluded that reverse reading of neural activity via nanoparticles remains “predominantly theoretical,” and the Johns Hopkins Lab, end 2024 admitted that picking up signals through the scalp and skull is still 🔗 Read original →